The transformative potential of gene therapy has been demonstrated in humans. However, there is an unmet need for non-invasive targeted gene delivery and regulation in the …
S Park, CW Park, JH Eom, MY Jo, HJ Hur, SK Choi… - Cell stem cell, 2024 - cell.com
Human embryonic stem cell (hESC)-derived midbrain dopaminergic (mDA) cell transplantation is a promising therapeutic strategy for Parkinson's disease (PD). Here, we …
P Douvaras, DF Buenaventura, B Sun… - Nature …, 2024 - nature.com
Mucopolysaccharidoses are inherited metabolic disorders caused by the deficiency in lysosomal enzymes required to break down glycosaminoglycans. Accumulation of …
Few models allow the study of neurite damage in the human central nervous system. We used here dopaminergic LUHMES neurons to establish a culture system that allows for (i) …
SJ Park, YY Kim, JY Han, SW Kim, H Kim… - Tissue Engineering and …, 2024 - Springer
Background: The development and use of human embryonic stem cells (hESCs) in regenerative medicine have been revolutionary, offering significant advancements in …
In vitro-generated pluripotent stem cell (PSC)-derived Pax3-induced (iPax3) myogenic progenitors display an embryonic transcriptional signature, but upon engraftment, the profile …
KS Chen, EJ Koubek, SA Sakowski, EL Feldman - Neurotherapeutics, 2024 - Elsevier
Rapid advances in biological knowledge and technological innovation have greatly advanced the fields of stem cell and gene therapies to combat a broad spectrum of …
Parkinson's disease (PD) is characterized by the loss of the dopaminergic nigrostriatal pathway which has led to the successful development of drug therapies that replace or …
MS Kim, S Yoon, J Choi, YJ Kim, G Lee - International Journal of …, 2024 - ijstemcell.com
Parkinson's disease (PD) is a neurodegenerative condition characterized by the loss of midbrain dopaminergic neurons, leading to motor symptoms. While current treatments …